The Lancet Public Health: Travel restrictions must be used in a targeted way to be effective at controlling local COVID-19 transmission, modelling study suggests

December 07, 2020

The measures may have limited impact on the epidemic within individual countries except those with low levels of the virus or that have strong travel links with countries experiencing high rates of infection.

The new study also suggests that travel restrictions can be effective in countries close to a tipping point for exponential growth - with a reproduction number, or R number, between 0.95 and 1.05 -but not in those where it is already spreading rapidly among the population.

Every country in the world had imposed some form of travel restrictions - which have high economic and social costs - by late April 2020 as part of efforts to control the spread of the COVID-19. However, until now, no studies had produced global estimates of how the risk of importing cases relates to local transmission levels. Findings from this study could enable policymakers to determine where travel restrictions will have a major impact on slowing local transmission, and where they will have little effect.

Professor Mark Jit from the London School of Hygiene and Tropical Medicine, who led the study, said: "We recognise that these measures carry a high economic and social cost, so it's important that governments use travel restrictions in a targeted way. Before introducing restrictions, they should take into account local infection figures, epidemic growth rates, and the volume of travellers arriving from countries heavily-affected by the virus." [1]

The authors used detailed flight data to compare the number of expected COVID-19 cases arriving from international flights (assuming no travel restrictions) with the number of infections arising from transmission within individual countries. The authors produced estimates of international travellers in May and September 2020 based on two scenarios. One scenario used flight data for the same months in 2019 (assuming no reduction in travel numbers) and the other scenario was based on the expected reduction in passenger numbers. Numbers of COVID-19 cases and infection rates were estimated using a mathematical model that adjusts recorded cases to take account of asymptomatic and unreported infections. Results were determined based on how imported COVID-19 cases would affect local epidemic growth rates, using country-specific R number estimates. Where imported cases accounted for more than 10% of infections within individual countries, they were considered to have a major impact on growth of the epidemic. The work estimated that when imported cases accounted for less than 10%, their impact on the growth of the epidemic is usually small, while those below 1% would have an almost undetectable effect on epidemic size. Publicly available country-specific R number estimates were used to identify countries close to their tipping point for exponential growth (R number between 0.95 and 1.05).

Had there been no travel restrictions or reduction in travel volumes in May 2020, the imported COVID-19 cases would account for more than 10% of infections in the majority of countries (102/136 countries included in the analysis). Imported cases would account for no more than 10% of infections in 34 out of 136 countries, and less than 1% in four. According to the estimates based on expected passenger numbers in May 2020, imported cases would have contributed to more than 10% of total incidence in 74 countries, less than 10% of total incidence in 62 countries, and to less than 1% in eight countries.

However, by September 2020, had there been no travel restrictions or reduction in travel volumes, imported cases would account for more than 10% of infections in only a small number of countries (56/162 countries). Imported cases account for less than 10% of infections in 106 out of 162 countries, and less than 1% in 21. According to the estimates based on expected passenger numbers in September 2020, travel restrictions would have contributed to more than 10% of infections in only 37 countries, less than 10% in 125 countries and less than 1% in only 44 countries (see appendix for country-level data).

In September 2020 with an expected reduction in passengers, of the 44 countries where imported cases would account for less than 1% of local infections in, 22 have R number estimates outside their tipping point (ie, R<0.95 or R>1.05), meaning that lifting travel restrictions in these countries is unlikely to cause local outbreaks (see appendix for country-level data). In May 2020 with an expected reduction in passengers, there are only five countries with R numbers estimates outside their tipping point where imported cases would account for less than 1% of local infections.

The findings indicate that international travel restrictions were most effective at limiting local transmission of the virus during earlier stages of the pandemic. This is because imported cases led to outbreaks in countries with very few - or no - existing cases.

The authors conclude that recommendations about international travel restrictions should not be applied uniformly. Countries must first consider local infection figures and epidemic growth rates, as well as the volume of travellers arriving from countries heavily-affected by COVID-19. For instance, in September 2020, the measures would be effective in New Zealand and China because the virus had been supressed to such low levels in both countries that the expected number of imported cases is similar to the local rate, meaning arrivals could trigger a new local wave of infections.

Estimates produced in the study assume that the COVID-19 rate among international travellers was the same as the general population of their country of origin. However, infected arrival rates are likely to be lower because people with symptoms are less likely to travel in the first place, and those who do may be detected during routine screening. People in the incubation period while traveling may develop symptoms and be detected, or self-declare illness upon arrival to their destination. This could mean that the number of imported COVID-19 cases that would occur without travel restrictions is overestimated in this study.

The authors also assessed only international flight data, meaning their analysis may not accurately capture the risk of COVID-19 spreading between countries with high volumes of land traffic (such as rail and road travel between countries in continental Europe).
-end-
NOTES TO EDITORS

This study was funded by Wellcome Trust, UK Department for International Development, European Commission, National Institute for Health Research, Medical Research Council, Bill & Melinda Gates Foundation. It was conducted by researchers from the London School of Hygiene and Tropical Medicine and the University of Hong Kong.

The labels have been added to this press release as part of a project run by the Academy of Medical Sciences seeking to improve the communication of evidence. For more information, please see:
http://www.sciencemediacentre.org/wp-content/uploads/2018/01/AMS-press-release-labelling-system-GUIDANCE.pdf
if you have any questions or feedback, please contact The Lancet press office pressoffice@lancet.com

[1] Quote direct from author and cannot be found in the text of the Article.

The Lancet

Related Infections Articles from Brightsurf:

Understanding the progress of viral infections
A team of researchers at the Institute for the Genetics of Heart Diseases at M√ľnster University created a viral expression model that can be used to simulate and analyse a large number of viral infections - including the one with SARS-CoV-2.

How viral infections associated with cancer become persistent?
A new study led by Pedro Simas, group leader at Instituto de Medicina Molecular (iMM; Portugal) and Kenneth M.

New drug formulation could treat Candida infections
With antimicrobial resistance (AMR) increasing around the world, new research led by the University of Bristol has shown a new drug formulation could possibly be used in antifungal treatments against Candida infections.

A 'shocking' new way to treat infections
New research from the University of Pittsburgh's Swanson School of Engineering introduces a revolutionary treatment for these infections.

Young infants with fever may be more likely to develop infections
Infants with a high fever may be at increased risk for infections, according to research from Penn State College of Medicine.

Hospital infections declining in Canada
There is good news on the infection front: infections acquired by patients in Canadian hospitals are declining, with a 30% reduction between 2009 and 2017, according to new research in CMAJ (Canadian Medical Association Journal).

Helminthic infections may be beneficial against HIV-1
Infection with parasitic helminths can reduce the susceptibility of T-cells to HIV-1 infection, according to a study published Sept.

Waking up sleeping bacteria to fight infections
Researchers in the group of Jan Michiels (VIB-KU Leuven Center for Microbiology) identified a mechanism of how sleepy bacteria wake up.

Typhoid vaccine may protect against other infections
New research by the University of Liverpool and Liverpool School of Tropical Medicine shows that vaccination with weakened strains of Salmonella may also protect against other infections.

New AI can detect urinary tract infections
New AI developed at the University of Surrey could identify and help reduce one of the top causes of hospitalisation for people living with dementia: urinary tract infections (UTI).

Read More: Infections News and Infections Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.